StonvexLoading…
StonvexStonvexStonvexCore line items from TFX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2025 2025-09-28 | Annual 2025 2025-06-29 | Annual 2025 2025-03-30 |
|---|---|---|---|---|
Revenue | $1.99B | $566.95M | $442.52M | $414.26M |
Operating Income | $118.37M | $-62.44M | $91.14M | $75.80M |
Net Income | $-905.64M | $-408.89M | $122.58M | $95.00M |
EPS (Diluted) | $-20.25 | $-9.24 | $2.77 | $2.07 |
Total Assets | $6.95B | Not available | Not available | Not available |
Total Liabilities | $3.82B | Not available | Not available | Not available |
Cash & Equivalents | $378.56M | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $1.45M | Not available | Not available | Not available |
Shares Outstanding | 44.72M | Not available | Not available | Not available |